The global scleroglucan market is estimated to exhibit growth at a remarkable CAGR during the forecast period 2022-2032. Increasing shift in end user preference from adopting xanthan gum to scleroglucan across the food manufacturing, owing to its better thermal stability is accelerating the sales in the global market.
Scleroglucan is a type of exopolysaccharides, long-chain polysaccharides that comprise of repeating units of sugars, obtained by a range of microorganisms. It is finding multifarious industrial applications across the diverse industries such as foods, personal care, pharmaceutical, and others on account of its favorable attributes such as viscosifying ability, wide stability over salinity, temperature, and pH, and high water-solubility.
Driven by this, scleroglucan is increasingly being used as suspension agents, thickening agents, membrane shaping agents, and agglomerating agents in cosmetic and pharmaceutical products, food additives, biocompatible materials, and others. This is projected to facilitate the demand for scleroglucan in the global market.
Growing vehicular fleet and rapidly increasing industrialization across the world have resulted in creating a huge demand for crude oil and petroleum products. Hence, governments in several countries are increasingly investing in the exploration and discovery of new oil & gas reserves to address the growing demand.
For instance according to the U.S. Energy Information Administration, in 2019, the Government of the U.S. announced the discovery of new oil reserves in New Mexico, North Dakota, and Texas with barrel capacity of nearly 1.1 Bn, 700 Mn, and 3.5 Bn, respectively. As scleroglucan is extensively used as fracturing, mud drilling, thickening, and completion fluids for enhanced oil recovery, such developments are projected to create high revenue generation opportunities in the global market.
Though the demand for scleroglucan is increasing at a rapid pace, complex production process, high cost of these exopolysaccharides, and need for advanced equipments for extraction of scleroglucan from microbes and fungi are anticipated to hamper the growth in the market.
In addition to this, growing availability of low-cost alternatives such as scleraldehyde, sclerox, and other agents is further hindering the sales in the global market.
South Asia is expected to emerge as a highly remunerative market for scleroglucan during the forecast period 2022-2032, as per the Future Market Insights.
Scleroglucan possesses antiviral, antimicrobial, and antitumor properties. It also demonstrates better immune-stimulatory effects than other biopolymers. Attributed to this, scleroglucan is increasingly gaining traction across the pharmaceutical industry and finding a large number of applications in the treatment of multiple diseases.
With rising prevalence of numerous diseases, conditions, and allergies such as cancer, arthritis, malaria, diarrhea, and others, consumption of drugs is rapidly increasing. As scleroglucan is used as an agglomerating agent in drug production, this rise in demand for therapeutic drugs is projected to bolster the sales in the South Asia market.
North America is estimated to register growth at a rapid CAGR in the global scleroglucan market between 2022 and 2032, states FMI.
The personal care & cosmetics industry is witnessing robust growth across North America, driven by the increasing demand for hygiene products, skin regime products, beauty products, make-ups, and others. Moreover, the growth in the sector is further elevated by rising emphasis on enhancing facial and body aesthetics.
With increasing customer inclination towards natural and organic products, leading personal care & cosmetics industry players are increasingly as natural stabilizers, thickening agents, emulsifiers, and gelling agents such as scleroglucan. Hence, increasing the sales of aforementioned products is projected to facilitate the demand in the North America market.
Some of the leading players in the scleroglucan market are General Mills, Cargill, Inc., Carbosynth Limited, ELICITYL, Parchem, CarboMer, Inc., CECA (Arkema), Mero Rousselot Satia Gmbh, Sanofi S.A., Shandong Qilu Biotechnology Group Co. Ltd., Food Ingredients, and others.
Key participants in the market are focusing at adopting collaboration, partnership, mergers & acquisitions strategies to gain edge in the highly competitive market
| Report Attribute | Details |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Countries Covered |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By Grade:
By Function:
By End Use:
By Region:
FMI projects the demand for scleroglucan market to expand at rapid value CAGR over the forecast period 2022-2032
The scleroglucan market is dominated by South Asia, and this trend is projected to continue for the assessment period.
General Mills, Cargill, Inc., Carbosynth Limited, ELICITYL, Parchem, CarboMer, Inc., CECA (Arkema), Mero Rousselot Satia Gmbh, Sanofi S.A., Shandong Qilu Biotechnology Group Co. Ltd., Food Ingredients, and others are some key scleroglucan manufacturer.
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Scleroglucan Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
